Skip to main content

Symptom · Long-haul vasomotor symptoms

Still flashing 10 years on. You're a third of women, not an outlier.

Most menopause writing assumes hot flashes last 'a few years' and quietly fade. The data says otherwise: a meaningful third of women keep having moderate-to-severe vasomotor symptoms more than a decade past their final period. If you're in that third and have been told you should be over this by now, here's what's actually true and what still works.

The Study of Women's Health Across the Nation (SWAN) followed thousands of women for over a decade and the headline number, that hot flashes last a median of 7.4 years, hides a much harder truth: about a third of women still have moderate-to-severe vasomotor symptoms more than 10 years past their final menstrual period. For Black women in the cohort the median duration was over 10 years; for women who started flashing in early perimenopause, longer still. If your hot flashes haven't followed the script, you are not unusual, you are the part of the data that doesn't get written about.

Step 01 of 04

What's happening

What's actually going on

Long-haul vasomotor symptoms aren't a different condition, they're the same thermoregulatory misfire that started in peri, just continuing. What's different is the explanation you've been given (or not given) for why they've kept going.

  • The KNDy neurons don't always quiet down

    Evidence

    Hot flashes are driven by hyperactive KNDy neurons in the hypothalamus. The original assumption was that they re-calibrate to low-estrogen baselines within a few years post-FMP. The newer evidence is that for a real subset of women they don't, or only partially do, and continue triggering thermoregulatory events for decades. The newer NK3 antagonist drugs (fezolinetant, and elinzanetant approved 2025) work directly on these neurons and don't 'expire' with menopause stage.

  • When you started predicts how long you'll go

    Evidence

    Women whose vasomotor symptoms started in early perimenopause (FMP-7+ years) had the longest durations in the SWAN cohort, often 11+ years total. Women whose symptoms started post-FMP tended to have shorter courses. So if you started early, the long course isn't a personal failure, it's the population pattern.

  • Race, BMI, and stress all shift the curve

    Evidence

    The SWAN study found Black women had a median total duration of over 10 years, the longest of any group studied. Higher BMI, smoking, depressive symptoms, and high perceived stress were all independently associated with longer durations. None of these are about willpower. They're about which biology you're working with.

  • Sleep destruction compounds the problem

    Evidence

    A decade of fragmented sleep from night sweats does its own damage, mood, cognition, cardiovascular risk, blood sugar regulation. The 'just live with it' framing underestimates how much harm comes from the downstream sleep loss, not the flashes themselves.

  • 'You should be over this' is cultural, not clinical

    Evidence

    There's no clinical guideline that says vasomotor symptoms are supposed to stop by year five, or that treatment becomes inappropriate at any specific time post-FMP. The current consensus from North American Menopause Society (NAMS), BMS and IMS is that severity and impact, not menopause stage, drive treatment decisions.

Step 02 of 04

What to try

What people actually find helps (in long-haul)

Almost every option that works in early menopause also works in long-haul. The conversations are sometimes harder to start, the answers aren't different.

  • Re-open the HRT conversation, even if you said no before

    Medical

    Many women in long-haul cases were told 'no' or 'too late' for HRT a decade ago, often based on the over-extrapolated 2002 Women’s Health Initiative (WHI) headlines. The current consensus has moved substantially: for women without contraindications who start HRT within ten years of their final menstrual period (FMP) and are still benefiting, continuing is reasonable with annual review. Starting later than that is more nuanced but not categorically off the table. A menopause-trained specialist can lay out your specific risk picture honestly.

  • Fezolinetant (NK3 antagonist), the newer non-hormonal lever

    Medical

    Approved in 2023, fezolinetant directly targets the KNDy neurons driving hot flashes. It works regardless of menopause stage, time since FMP, or whether you've tried HRT before. Trial data shows around a 60% reduction in moderate-to-severe vasomotor symptoms. Liver monitoring is required in the first months. A real option for long-haul cases that aren't suitable for HRT. Elinzanetant (Lynkuet, Bayer) was approved in 2025 as a second NK3 antagonist — dual-acting on the same pathway, with added benefit on sleep and mood disturbance, and no liver-monitoring requirement.

  • Other non-hormonal prescriptions still work

    Medical

    Low-dose paroxetine (the only FDA-approved selective serotonin reuptake inhibitor (SSRI) for vasomotor symptoms (VMS)), venlafaxine, gabapentin and oxybutynin all have randomized-trial evidence and don't lose effect with time post-FMP. None work as well as HRT, but all outperform doing nothing. Worth a conversation if you've ruled out hormones.

  • CBT-Meno, evidence holds in long-haul cases

    Evidence

    The cognitive behavioural therapy protocol designed for menopause has good trial evidence for reducing how much hot flashes bother you, even when frequency stays the same. It works at any stage post-FMP. Ask your doctor for a referral or look for trained therapists through the British Menopause Society directory.

  • Treat the sleep, separately

    Evidence

    A decade of fragmented sleep deserves its own intervention, not 'wait for the flashes to stop'. Cognitive behavioural therapy (CBT) for insomnia (CBT-I), addressing any obstructive sleep apnea (which becomes more common post-FMP), and a serious bedroom-cooling setup are all worth pursuing in parallel.

  • Find a doctor or specialist who actually treats long-haul

    Medical

    If you've been told 'you should be over this by now' or 'we don't really do hormones for women your age', that's the signal to find someone else. The Menopause Society (US) and British Menopause Society (UK) directories filter for menopause-trained doctors. The right specialist will treat the symptom, not your menopause stage.

  • Trigger work still helps, even after years

    Personal

    If you've never done a couple of weeks of focused trigger-tracking, do it now. Members consistently identify two or three personal triggers (often alcohol, late caffeine, hot showers before bed) within ten days. You can put them back, you'll just know what they cost.

A note from us: these are things women in this community have found helpful, not medical advice or a protocol. Doses, products, and routines vary person to person, run anything new past your doctor or pharmacist first, especially if you're on medication or in surgical or medically-induced menopause.

Step 03 of 04

What to track

Signals worth paying attention to

Long-haul vasomotor needs the same tracking as new vasomotor, the data is just more useful because you have a longer baseline.

  • Frequency and severity, separately

    Personal

    Three mild flashes is not the same as one that takes you out. Tracking both gives you the cleanest before/after when you change anything.

    Log this
  • Sleep quality, not just hours

    Evidence

    Night sweats fragment deep sleep without always waking you. A wearable that tracks wake events makes the pattern visible.

  • How much it's actually costing you

    Personal

    Mood, work, relationships, exercise. Long-haul VMS often quietly shapes everything. Naming the cost is what often re-opens the treatment conversation.

    Log this
  • Cardiovascular markers, annually

    Medical

    Severe long-duration VMS are independently associated with higher cardiovascular risk. Lipids, BP, fasting glucose deserve attention regardless.

Step 04 of 04

When to seek help

When it's not 'just' long-haul flashes

A long course of vasomotor symptoms is normal. A few specific patterns are not, and warrant a workup.

  • Sudden new onset of severe flashes after years of quiet

    Medical

    If your VMS had quieted and then came back loudly years later, that's worth investigating, sometimes a medication change, thyroid, occasionally other causes. Not always menopause coming back.

  • Drenching night sweats with weight loss, fever, or swollen glands

    Medical

    This combination is rarely menopause alone and warrants prompt investigation. Don't wait it out. See a doctor within a week.

  • Flashes plus chest pain, breathlessness, or dizziness

    Medical

    Cardiac symptoms in midlife and older women are routinely misread as menopause. If a flash comes with crushing chest pressure, jaw pain, or one-sided arm pain, call emergency services.

  • You've been refused care because of your age

    Personal

    Age alone isn't a contraindication to treating long-haul VMS. If you've been told you're 'too old for hormones' or 'past the point of treatment', that's usually outdated guidance. A menopause-trained specialist can give you the actual risk-benefit picture for you.

    Add to doctor's list

What do I do next?

Pick one. Today, not someday.

  1. Track it for two weeks

    Start a daily log for hot flashes. Two weeks of dots makes a pattern visible, and gives you something concrete to bring to a doctor or specialist.

    Open symptom log
  2. Read the related guide

    This sits inside a bigger picture. all doorways walks through the wider pattern and the trade-offs.

    Open all doorways
  3. Find the right kind of help

    The right help in midlife often isn't one doctor, it's a small team. Browse a directory pre-filtered to the modality that matches this guide.

    Find a practitioner
  4. Talk to your doctor

    Use the printable conversation script: what to say, what to ask for, and how to ask for a second opinion if the first appointment didn't land.

    Open conversation script

This guide is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Reviewed by: Nila editorial team. Last updated: . ~6 min read
How we review content